← All trials
NCT04066816
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 20, 2019
- Primary completion
- May 19, 2020
- Completion date
- May 19, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of ConnecticutLead sponsor
- University of ConnecticutOverall official - principal investigator
- University of ConnecticutStudy director
- University of ConnecticutReponsible party - principal investigator
- California Walnut CommissionCollaborator
- Jackson LaboratoryCollaborator
- American Institute for Cancer Research (AICR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.